DNDN: (My guess is that the FDA is now experiencing some of the fiercest in-fighting between divisions, CDER vs. CBER, that it has ever experienced. The fact that Scher has taken this whole mess public is testimony to that. The whole process is rather fascinating, if you're into this sort of stuff--lol)
I agree, at least for those of us without positions.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.